---
title: "CMS 为 YARTEMLEA®（narsoplimab-wuug）分配了永久报销 J 码 | 奥麦罗制药股票新闻"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/283003072.md"
description: "CMS 为 YARTEMLEA® (narsoplimab-wuug) 指派永久报销 J 代码 | OMER 股票新闻"
datetime: "2026-04-16T04:45:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283003072.md)
  - [en](https://longbridge.com/en/news/283003072.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283003072.md)
---

# CMS 为 YARTEMLEA®（narsoplimab-wuug）分配了永久报销 J 码 | 奥麦罗制药股票新闻

CMS 为 YARTEMLEA® (narsoplimab-wuug) 指派永久报销 J 代码 | OMER 股票新闻

### 相关股票

- [OMER.US](https://longbridge.com/zh-CN/quote/OMER.US.md)
- [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md)

## 相关资讯与研究

- [盘前趋势｜再生元制药（REGN.US）](https://longbridge.com/zh-CN/news/286964437.md)
- [“搞钱”，才是 Revolution 千亿神话密码](https://longbridge.com/zh-CN/news/286888792.md)
- [默沙东 ADC 药物达 III 期主要终点](https://longbridge.com/zh-CN/news/286929703.md)
- [奥麦罗制药｜10-K：2025 财年营收 0 美元](https://longbridge.com/zh-CN/news/281237922.md)
- [制药巨头集体拥抱 AI 智能体：百时美施贵宝向 3 万员工推广 Claude](https://longbridge.com/zh-CN/news/287074661.md)